ClinicalTrials.Veeva

Menu
S

Southwest Retina Specialists | Amarillo, TX

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Ranibizumab
KSI-301
ranibizumab
Zimura
APL-2
Aflibercept
EYE103
Avacincaptad pegol
Bevacizumab
dexamethasone

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 11 total trials

A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME (BRUNELLO)

EYE-RES-102 is a randomized, double masked pivotal study to evaluate the efficacy and safety of 2 dose levels of EYE103 in comparison with the active...

Enrolling
Diabetic Macular Edema (DME)
Drug: EYE103
Drug: Ranibizumab

The purpose of this study is to assess long-term safety of avacincaptad pegol intravitreal administration for patients with geographic atrophy (GA) w...

Active, not recruiting
Age-Related Macular Degeneration
Geographic Atrophy
Drug: avacincaptad pegol

Trial sponsors

Jaeb Center for Health Research logo
E
A
Astellas logo
I
Kodiak Sciences logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems